Literature DB >> 12219181

Cardiovascular control in experimental diabetes.

K De Angelis1, B D Schaan, C Y Maeda, P Dall'Ago, R B Wichi, M C Irigoyen.   

Abstract

Several studies have reported impairment in cardiovascular function and control in diabetes. The studies cited in this review were carried out from a few days up to 3 months after streptozotocin administration and were concerned with the control of the circulation. We observed that early changes (5 days) in blood pressure control by different peripheral receptors were maintained for several months. Moreover, the impairment of reflex responses observed after baroreceptor and chemoreceptor stimulation was probably related to changes in the efferent limb of the reflex arc (sympathetic and parasympathetic), but changes also in the central nervous system could not be excluded. Changes in renal sympathetic nerve activity during volume expansion were blunted in streptozotocin-treated rats, indicating an adaptive natriuretic and diuretic response in the diabetic state. The improvement of diabetic cardiovascular dysfunction induced by exercise training seems to be related to changes in the autonomic nervous system. Complementary studies about the complex interaction between circulation control systems are clearly needed to adequately address the management of pathophysiological changes associated with diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12219181     DOI: 10.1590/s0100-879x2002000900010

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  18 in total

1.  Angiotensin II-Superoxide Signaling and Arterial Baroreceptor Function in Type-1 Diabetes Mellitus.

Authors:  Yu-Long Li
Journal:  J Diabetes Metab       Date:  2013

2.  The Effect of Regular Moderate Exercise on miRNA-192 Expression Changes in Kidney of Streptozotocin-Induced Diabetic Male Rats.

Authors:  Hajar Oghbaei; Naser Ahmadi Asl; Farzam Sheikhzadeh; Mohammad Reza Alipour; Amir Mahdi Khamaneh
Journal:  Adv Pharm Bull       Date:  2015-03-05

3.  Hyperoxia-induced cardiotoxicity and ventricular remodeling in type-II diabetes mice.

Authors:  Jennifer Leigh Rodgers; Eva Samal; Subhra Mohapatra; Siva Kumar Panguluri
Journal:  Heart Vessels       Date:  2017-12-05       Impact factor: 2.037

4.  Influence of fluvastatin on cardiac function and baroreflex sensitivity in diabetic rats.

Authors:  Fang Xie; Chao Sun; Li-hua Sun; Jing-yuan Li; Xin Chen; Hui Che; Guan-yi Lu; Bao-feng Yang; Jing Ai
Journal:  Acta Pharmacol Sin       Date:  2011-03       Impact factor: 6.150

Review 5.  Diabetes and cardiovascular autonomic dysfunction: application of animal models.

Authors:  Katia De Angelis; Maria Claudia Irigoyen; Mariana Morris
Journal:  Auton Neurosci       Date:  2008-12-02       Impact factor: 3.145

6.  Role of hyperglycaemia in the pathogenesis of hypotension observed in type-1 diabetic rats.

Authors:  I-Min Liu; Cheng Kuei Chang; Shiow-Wen Juang; Dai-Huang Kou; Yat-Ching Tong; Kai-Chun Cheng; Juei-Tang Cheng
Journal:  Int J Exp Pathol       Date:  2008-08       Impact factor: 1.925

7.  Increase of ATP-sensitive potassium (K(ATP)) channels in the heart of type-1 diabetic rats.

Authors:  Zhih-Cherng Chen; Yung-Ze Cheng; Li-Jen Chen; Kai-Chun Cheng; Yin- Xiao Li; Juei- Tang Cheng
Journal:  Cardiovasc Diabetol       Date:  2012-01-18       Impact factor: 9.951

8.  Nicotinamide attenuates streptozotocin-induced diabetes complications and increases survival rate in rats: role of autonomic nervous system.

Authors:  Paula L Cruz; Ivana C Moraes-Silva; Amanda A Ribeiro; Jacqueline F Machi; Marcelo Dantas Tavares de Melo; Fernando Dos Santos; Maikon Barbosa da Silva; Celia Maria Cassaro Strunz; Elia Garcia Caldini; Maria-Claudia Irigoyen
Journal:  BMC Endocr Disord       Date:  2021-06-28       Impact factor: 2.763

9.  Maximal exercise test is a useful method for physical capacity and oxygen consumption determination in streptozotocin-diabetic rats.

Authors:  Bruno Rodrigues; Diego M Figueroa; Cristiano T Mostarda; Marcelo V Heeren; Maria-Cláudia Irigoyen; Kátia De Angelis
Journal:  Cardiovasc Diabetol       Date:  2007-12-13       Impact factor: 9.951

10.  Neurohumoral stimulation in type-2-diabetes as an emerging disease concept.

Authors:  R U Pliquett; M Fasshauer; M Blüher; R Paschke
Journal:  Cardiovasc Diabetol       Date:  2004-03-17       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.